Globus Medical (NYSE: GMED) — Perfil da empresa, notícias e dados financeiros
Globus Medical specializes in musculoskeletal solutions to improve surgical outcomes for spine and orthopedic care.
Globus Medical
Globus Medical is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company designs, manufactures, and markets procedurally integrated surgical products and enabling technologies used in orthopedic, spine, and joint reconstruction procedures. Its product portfolio includes spinal implants, expandable interbody technology, surgical navigation systems, robotic technology, orthopedic trauma plates and screws, joint replacement systems, power surgical tools, and regenerative biologics. Globus Medical serves healthcare professionals, hospitals, and surgeons globally, providing clinical education and integrated surgical workflows to improve patient outcomes.
Resumo
Operações
Produtos e/ou serviços de Globus Medical
- Spine Procedures: Comprehensive portfolio of spinal fusion implants, expandable interbody spacers, motion preservation cervical discs, fixation systems, and procedurally integrated access tools used in cervical, thoracic, lumbar, and complex deformity surgical procedures globally.
- Enabling Technologies: Robotic navigation platforms, imaging systems, and digital surgical ecosystems including ExcelsiusGPS, ExcelsiusFlex, and Excelsius3D, engineered for pre-operative planning, intra-operative navigation, and automated intraoperative imaging during spine and orthopedic surgeries.
- Orthopedic Trauma: Internal fixation plating systems, intramedullary nailing systems, specialized extremity hardware, and Precice magnetically adjustable limb reconstruction devices designed for treating complex upper and lower extremity bone fractures and musculoskeletal deformities.
- Joint Reconstruction: Comprehensive total hip and knee replacement systems, unicondylar knee implants, revision joint devices, and integrated surgical technologies used in primary and revision joint replacement procedures across surgical centers internationally.
- Power Portfolio: Surgical power tools and accessories, including DuraPro oscillating systems and Verzera navigated high-speed drills, engineered to integrate directly with robotic navigation platforms and streamline surgical workflows in operating rooms.
- Regenerative Biologics: Synthetic bone graft substitutes, cellular allografts, demineralized bone matrix, amniotic membrane matrices, and autologous platelet-rich plasma and bone marrow aspirate concentrate systems designed to promote bone healing and tissue regeneration.
equipe executiva do Globus Medical
- David C. PaulCo-Founder & Executive Chairman
- Keith W. PfeilCEO, President & Director
- Kyle R. KlinSenior VP & CFO
- Kelly G. HullerExecutive VP, General Counsel & Corporate Secretary
- Brian J. KearnsSenior Vice President of Business Development & Investor Relations
Principais indicadores financeiros
Resultados divulgados pela Globus Medical, em USD.
- Cap. de mercado
- 10,9 bi
- Receita (TTM)
- 3,1 bi
- P/L
- 20.7
- LPA (diluído, TTM)
- 3.9
- Dividend yield
- —
- Margem de lucro
- 17.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,9 bi | 479,8 mi | 537,9 mi | |
| 2,5 bi | 166 mi | 103 mi | |
| 1,6 bi | 133,1 mi | 122,9 mi | |
| 1 bi | 228 mi | 190,2 mi |